IOVA
Price
$2.05
Change
+$0.25 (+13.89%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
684.57M
62 days until earnings call
PLX
Price
$1.58
Change
+$0.07 (+4.61%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
125.78M
73 days until earnings call
Interact to see
Advertisement

IOVA vs PLX

Header iconIOVA vs PLX Comparison
Open Charts IOVA vs PLXBanner chart's image
Iovance Biotherapeutics
Price$2.05
Change+$0.25 (+13.89%)
Volume$292.98K
Capitalization684.57M
Protalix BioTherapeutics
Price$1.58
Change+$0.07 (+4.61%)
Volume$7.56K
Capitalization125.78M
IOVA vs PLX Comparison Chart
Loading...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOVA vs. PLX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Buy and PLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (IOVA: $1.79 vs. PLX: $1.52)
Brand notoriety: IOVA and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOVA: 50% vs. PLX: 46%
Market capitalization -- IOVA: $684.57M vs. PLX: $121M
IOVA [@Biotechnology] is valued at $684.57M. PLX’s [@Biotechnology] market capitalization is $121M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOVA’s FA Score shows that 1 FA rating(s) are green whilePLX’s FA Score has 1 green FA rating(s).

  • IOVA’s FA Score: 1 green, 4 red.
  • PLX’s FA Score: 1 green, 4 red.
According to our system of comparison, PLX is a better buy in the long-term than IOVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOVA’s TA Score shows that 7 TA indicator(s) are bullish while PLX’s TA Score has 6 bullish TA indicator(s).

  • IOVA’s TA Score: 7 bullish, 1 bearish.
  • PLX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than PLX.

Price Growth

IOVA (@Biotechnology) experienced а -1.91% price change this week, while PLX (@Biotechnology) price change was -4.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

IOVA is expected to report earnings on Aug 07, 2025.

PLX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($685M) has a higher market cap than PLX($126M). PLX YTD gains are higher at: -19.149 vs. IOVA (-75.743). PLX has higher annual earnings (EBITDA): 7.16M vs. IOVA (-354.01M). IOVA has more cash in the bank: 360M vs. PLX (34.7M). PLX has less debt than IOVA: PLX (5.24M) vs IOVA (53.7M). IOVA has higher revenues than PLX: IOVA (213M) vs PLX (59.8M).
IOVAPLXIOVA / PLX
Capitalization685M126M544%
EBITDA-354.01M7.16M-4,944%
Gain YTD-75.743-19.149396%
P/E RatioN/A31.60-
Revenue213M59.8M356%
Total Cash360M34.7M1,037%
Total Debt53.7M5.24M1,026%
FUNDAMENTALS RATINGS
IOVA vs PLX: Fundamental Ratings
IOVA
PLX
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9465
PRICE GROWTH RATING
1..100
9765
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for PLX (66) in the Servicestothe Health Industry industry. This means that IOVA’s stock grew somewhat faster than PLX’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that IOVA’s stock grew similarly to PLX’s over the last 12 months.

PLX's SMR Rating (65) in the Servicestothe Health Industry industry is in the same range as IOVA (94) in the Biotechnology industry. This means that PLX’s stock grew similarly to IOVA’s over the last 12 months.

PLX's Price Growth Rating (65) in the Servicestothe Health Industry industry is in the same range as IOVA (97) in the Biotechnology industry. This means that PLX’s stock grew similarly to IOVA’s over the last 12 months.

PLX's P/E Growth Rating (9) in the Servicestothe Health Industry industry is significantly better than the same rating for IOVA (100) in the Biotechnology industry. This means that PLX’s stock grew significantly faster than IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IOVAPLX
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIOIX12.620.05
+0.40%
M3Sixty Income and Opportunity Instl
JVACX37.16N/A
N/A
JPMorgan Value Advantage C
RDWCX11.89N/A
N/A
American Funds Dvlpg Wld Gr&Inc R3
STCZX16.06N/A
N/A
Virtus Silvant Large-Cap Growth Stk R6
LMSAX36.44N/A
N/A
ClearBridge Small Cap A

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with PLX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then PLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-1.91%
PLX - IOVA
50%
Loosely correlated
-5.00%
ADMA - IOVA
46%
Loosely correlated
-1.92%
VCYT - IOVA
43%
Loosely correlated
-1.17%
ROIV - IOVA
42%
Loosely correlated
-0.18%
CRSP - IOVA
42%
Loosely correlated
+1.37%
More

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-5.00%
IOVA - PLX
50%
Loosely correlated
-1.91%
STOK - PLX
31%
Poorly correlated
-0.73%
ZNTL - PLX
31%
Poorly correlated
-2.00%
CPRX - PLX
31%
Poorly correlated
+0.28%
SNDX - PLX
31%
Poorly correlated
+1.82%
More